which led to its approval by FDA for treatment of HIV infection in 1998, has been attributed in large part to the rigidity afforded by its double bond between C2Ј and C3Ј 5, 6) and to its cyclopropylamino group, which increases its lipophilicity and its ability to penetrate into the central nervous system, an important reservoir of the HIV and other viruses. 7) Inspired on that, our research group has been investigating the biological properties of other carbanucleosides as well as their 1Ј-homo-counterparts, in which the planar region of the carbocyclic double bond present in abacavir is replaced by a benzene ring [8] [9] [10] or by an aromatic heterocycle, [11] [12] [13] seeking to modify the lipophilicity and polar interactions of this region of the molecule while preserving its rigidity. Most of the new compounds showed little if any antiviral activity against HIV, but in a broader antiviral survey some of them in which there is a pyrazol ring fused to the cyclopentene ring such as in 2, proved to be highly active against varicellazoster virus and cytomegalovirus at subcytotoxic concentration, 12) while an important number of both indan and cyclopenta[c]pyrazole derivatives were found to have considerable cytostatic activity against human T lymphocytes (Molt4/ C8 and CEM/0 cells). 8, 9, 13) These results pushed us to further explore the field of compounds in which an heterocycle is fused to the cyclopentene moiety of the carbanucleoside. Here we report a synthetic way that leads to 1Ј-homonucleoside analogues of the type A, based on a 6,7-dihydro-5H-cyclopenta[b]pyrazine scaffold.
Results and Discussion
Our work was initially planned on a convergent synthesis (Chart 1) that brings together the preformed main blocs of the final structure through a Mitsunobu coupling, as in some previous analogues. 13) Now, while several purine derivatives are commercially available, this strategy compelled us to achieve a properly functionalised cyclopenta[b]pyrazine derivative, and a dimethanol derivative of the type B was envisaged as the key synthetic intermediate. B would be available through a sequence based on the retrosynthetic pathway B⇒E depicted in Chart 1.
Following 1,3-diacetylation of 2-imidazolone, compound 3 (Chart 2) was obtained as per Whitney. 14) Hydroxylation with OsO 4 and methylmorpholine N-oxide 15) in acetone/water afforded a 74% yield of glycol 4, which upon treatment with dimethoxypropane gave acetonide 5. An attempt to convert 5 into diamine 7 in one step by heating with KOH in methanol at 155°C afforded a complex mixture including only traces of the desired product, while a two-steps process, heating of compound 5 with KOH in methanol at 65°C, isolation of the resulting imidazolone 6, and heating of 6 with KOH in methanol at 155°C in a sealed tube, 16) afforded a good yield of a product that could be by identified as 7 by 1 H-NMR spectroscopy. Due to the lability and volatility of this kind of compounds, 16) 7 was used in the next step without further pu-rification. Thus, crude 7 was condensed with benzil in THF with acetic acid as catalyst, and the resulting dihydropyrazine (8) was aromatized in 86% yield by refluxing with 4,5-dichloro-3,6-dioxo-1,4-cyclohexadiene-1-2-dicarbonitrile (DDQ) in toluene for 2.5 h. Attempts to achieve mild cleavage of the acetonide moiety of compound 9 (treatment with 60% AcOH or HCO 2 H, at r.t. or under reflux, or with HClO 4 or BF 3 · OEt 2 at r.t.) were all unsuccessful, the starting material being recovered or intractable mixtures of unidentified products being obtained. Finally diol 10 was prepared in good yield by moderate heating of 9 in EtOH in presence of HCl.
Oxidative cleavage of 10 with sodium periodate on silica gel 17) then gave dialdehyde 11 (as identified by IR spectroscopy), and reduction of crude 11 with NaBH 4 in methanol finally afforded an approximately 2 : 1 mixture of the desired cis-diol 12 and its diastereomer 13; partial epimerization is presumed to have occurred during these last two steps.
Diastereomers 12 and 13 were clearly distinguished and cis/trans relative configurations initially assigned to them on the basis of their 1 H-NMR spectra: each of the chemically unequivalent C6 protons of cis-diol 12 gives rise to a doublet of triplets, at d 1.61 (Jϭ9.3, 13.1 Hz) and d 2.51 (Jϭ8.3, 13.1 Hz), while the two chemically equivalent C6 protons of trans-diol 13 give rise to a single triplet at d 2.18 (Jϭ7.3 Hz). Compound 13 was then conclusively identified by X-ray crystallography (Fig. 1) . 18) Several attempts to perform Mitsunobu processes with 6-chloropurine on 12 or monoprotected derivatives of it were fruitless and we then turned to more classical nuecleophilic displacements. Esterification of 12 with acetic anhydride and pyridine afforded a mixture including the starting compound, its diacetate, and the monoacetate 14, which was converted into mesylate 15 in 69% yield by treatment with mesyl chloride, triethylamine and 4-(dimethylamino)pyridine (DMAP) at 0°C (Chart 2). Coupling 15 with 6-chloropurine by reaction in DMF in the presence of NaH and 18-crown-6 ether 11) finally afforded nucleoside analogue 16 in 37% yield; an alkene, thought to be 17 (two singlets at 5.36 and 6.17 ppm in the 1 H-NMR spectra) and formed from 15, presumably through a dehydromesyloxylation promoted by the basic medium, 11) was also detected as the main by-product (in an estimated 25% yield).
Suitability of chloropurine 16 to serve as an appropriate key intermediate for the preparation of nucleoside analogues of this new class was shown through its smooth conversion into methoxypurine analogue 18 by treatment with methanol and aqueous HCl at room temperature (r.t.), and into amino derivatives 19 and 20, by reaction with liquid ammonia and cyclopropylamine, respectively.
In conclusion, this paper describes a convenient synthetic procedure for the preparation of novel purinyl-1Ј-homocarbanucleoside derivatives 16, 18, 19 and 20, as examples of an interesting new template in which the double bond of the cyclopentenyl nucleosides is embedded in a pyrazine ring, thus opening a route to a wide variety of other purinyl derivatives 
Experimental
All chemical used were of reagent grade and were obtained from Aldrich Chemical Co. and used without further purification. Melting points were measured in a Reichert Kofler Thermopan and are uncorrected. Infrared spectra were recorded on a Perkin-Elmer 1640 FT-IR spectrophotometer. 1 
Hand 13
C-NMR spectra were recorded in a Bruker AMX-300 spectrometer at 300 and 75 MHz, respectively, using TMS as internal standard (chemical shifts in d values, J in Hz). Microanalyses were performed in a LECO CHNS-932 Elemental Analyser at the University of Santiago Microanalysis Service. Analyses indicated by the symbols of elements were within Ϯ0.4% of the theoretical values. Flash chromatography was performed on silica gel (Merck 60, 230-240 mesh) and analytical TCL on pre-coated silica gel plates (Merck 60, F 254 , 0.25 mm). MPLC separations were carried out using a Biotage Flash 4Di system with a Biotage column (Si-40B, silica gel). XRay diffraction data were collected in an Enraf-Nonius CAD4 automatic diffractometer using the programme CAD4-EXPRESS.
(3aR,4R,5R,6S,7S,7aS)-1,3-Diacetyl-5,6-dihydroxyperhydro-4,7-methanobenzo-imidazol-2-one (4) A solution of 3 (4.0 g, 17 mmol) in (4 : 1 acetone/water) (35 ml) was heated to 40°C and methylmorpholine Noxide (2.2 g, 18.9 mmol) was added, followed after 5 min at the same temperature by a 4% (w/w) solution of OsO 4 in water (0.5 ml), which immediately caused the mixture to turn brown. After 90 min stirring at 40°C the reaction mixture was filtered through celite, concentrated, and treated with saturated NH 4 Cl solution. This mixture was extracted with EtOAc, the organic phase was washed with brine and dried over Na 2 SO 4 , the solvent was removed under reduced pressure, and purification of the residue by chromatography on silica gel with 1 : 1 hexane/EtOAc as eluent afforded 4 as a white solid (3.55 g, yield 74% (3aR,4R,5R,6S,7S,7aS)-2,2-Dimethylperhydro-4,7-methano-1,3-benzodioxole-5,6-diamine (7) A suspension of 6 (1.9 g, 8.5 mmol) in methanol (8.6 ml) and 50% KOH (21 ml) was heated at 155°C in a sealed tube for 48 h, allowed to cool to r.t., concentrated, and extracted with CHCl 3 . The CHCl 3 phase was dried over Na 2 SO 4 , and removal of the solvent under reduced pressure left a yellow solid (1.63 g) that was used in the next step without further purification. 2 mmol) in THF (6 ml) was added to a solution of crude 7 (1.63 g, 8.2 mmol) in the same solvent (20 ml), a catalytic amount of acetic acid was added, and the mixture was refluxed until reaction was deemed complete on the basis of TLC monitoring (4 h). Concentration to dryness left a yellow solid that was purified by chromatography on silica gel with (2 : 1) hexane/EtOAc as eluent followed by recrystallization from ethanol ( 31 g, 3 .54 mmol) in ethanol (60 ml) at 0°C, and the mixture was heated at 70°C until TLC showed no starting compound (10 h cis and (؎)-trans) (11) A 0.65 M aqueous solution of NaIO 4 (6.06 ml) was added to a suspension of silica gel (5.9 g) in CH 2 Cl 2 (50 ml), and the mixture was shaken vigorously by hand and, following the formation of a flaky precipitate, added to a solution of 10 (1.0 g, 3.03 mmol) in CH 2 Cl 2 (6.0 ml). This mixture was stirred at room temperature until TLC showed no starting compound (15 min), and was then filtered through Na 2 SO 4 and concentrated under reduced pressure, affording a vivid orange solid that was identified as compound 11 (on the basis of the strong carbonyl band at 1723 cm Ϫ1 in its IR spectrum) and was used without further purification in the next step.
cis-2,3-Diphenyl-6,7-dihydro-5H-cyclopenta[b]pyrazine-5,7-dimethanol (12) and (؎)-trans-2,3-Diphenyl-6,7-dihydro-5H-cyclopenta-[b]pyrazine-5,7-dimethanol (13) NaBH 4 (56.74 mg, 1.5 mmol) was added to a solution of 10 (90 mg, 0.27 mmol) in MeOH (15 ml) and the mixture was left stirring (colour change). When TLC showed no remaining starting compound (30 min), water (10 ml) was added and stirring was continued for 15 min, after which the methanol was removed under reduced pressure and the remaining aqueous solution was extracted with EtOAc. The organic phase was dried with Na 2 SO 4 and concentrated to dryness, leaving a solid that following chromatography on a silica gel column with (1 : 2) hexane/EtOAc as eluent afforded a solid foam (81 mg, yield 80%) with two components. Further chromatography on an MPLC column with (98 : 2) CH 2 Cl 2 /MeOH as eluent afforded the 12 (52 mg) followed by the 13 (29 mg). Single crystals suitable for X-ray diffractometry were obtained by dissolving a sample of 13 in the least possible quantity of cold EtOAc in an open vial that was then placed in a larger container with a little hexane at the bottom; the container was closed, and after a few days in a cool, dark place free from vibrations some single crystals were formed, one of which was analysed by X-ray diffractometry.
(؎)-cis-[7-(Hydroxymethyl)-2,3-diphenyl-6,7-dihydro-5H-cyclopenta[b]pyrazin-5-yl]methyl Acetate (14) Acetic anhydride (180 mg, 1.8 mmol) was added to a solution of 12 (60 mg, 0.18 mmol) in pyridine (2 ml), the mixture was stirred under argon at r.t. for 12 h, water was added, and following extraction with AcOEt the organic phase yielded a residue from which chromatography on silica gel with hexane/EOtAc (3 : 1) as eluent separated the diester (12 mg), the desired monoester 14 (as oil) (53 mg, yield 52%), and starting diol 12 (10 mg (5 ml) in an ice bath were added Et 3 N (0.5 ml) and a catalytic amount of DMAP. Following dropwise addition of mesyl chloride (0.25 ml, 3.2 mmol), the mixture was stirred at r.t. for 2 h, refluxed for 12 h with TLC monitoring, poured over ice-water, and left stirring for 1 h, after which the organic phase was drawn off, washed with 1 N NaOH and brine, dried with Na 2 SO 4 and concentrated under reduced pressure, affording compound 15 as an oil that was purified by column chromatography with (2 : 1) hexane/AcOEt as eluent (330 mg, yield 69% (305 mg, 0.59 mmol), MeOH (4 ml) and HCl 1 N (4 ml) was stirred at r.t. for 14 h, and after removal of the solvent the resulting residue was dissolved in EtOAc (20 ml). This solution was washed with brine (20 ml) and the solvent removed under reduced pressure, leaving a oil (260 mg) that after chromatography on silica gel with CH 
